Protara Therapeutics, Inc. Property, Plant and Equipment, Gross
Protara Therapeutics, Inc. (TARA) had Property, Plant and Equipment, Gross of $2.23 million as of 2025-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentGross · last filed 2026-03-10
- 2025-12-31: Property, Plant and Equipment, Gross $2.23M.
- 2024-12-31: Property, Plant and Equipment, Gross $2.13M.
- 2023-12-31: Property, Plant and Equipment, Gross $2.12M.
- 2022-12-31: Property, Plant and Equipment, Gross $2.08M.
| Period end | Property, Plant and Equipment, Gross |
|---|---|
| 2025-12-31 | $2.23M 10-K · filed 2026-03-10 |
| 2024-12-31 | $2.13M 10-K · filed 2026-03-10 |
| 2023-12-31 | $2.12M 10-K · filed 2025-03-05 |
| 2022-12-31 | $2.08M 10-K · filed 2024-03-13 |
| 2021-12-31 | $1.96M 10-K · filed 2023-03-08 |
| 2020-12-31 | $1.36M 10-K · filed 2022-03-09 |
| 2019-12-31 | $475.00K 10-K · filed 2021-03-11 |
| 2019-06-30 | $1.10M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $1.11M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $1.09M 10-K · filed 2020-03-20 |
| 2017-12-31 | $971.00K 10-K · filed 2019-03-13 |
| 2016-12-31 | $937.00K 10-K · filed 2018-03-14 |
| 2015-12-31 | $665.00K 10-K · filed 2017-03-16 |
| 2014-12-31 | $467.00K 10-K · filed 2016-03-14 |
| 2013-12-31 | $416.00K 10-K · filed 2015-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |